An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University


December 8, 2020 — After recovering from COVID-19, some patients are left with chronic, debilitating pain, numbness or weakness in their hands, feet, arms and legs due to unexplained nerve damage. A new Northwestern Medicine study shows how advanced imaging technology can pinpoint what may have caused patients' nerve damage and help determine the best course of treatment.

"Let's say you have numbness in your fingers. That might actually be due to problems in your neck, elbow or wrist, and the best way to figure it out is with an MRI or ultrasound," said lead author Swati Deshmukh, M.D., assistant professor of radiology at Northwestern University Feinberg School of Medicine and a Northwestern Medicine radiologist. "We offer advanced imaging that shows even really, really small nerves, which helps us localize where the problem is, assess the severity and suggest what might be causing it."

This is the first known publication to summarize how these advanced imaging techniques can help physicians identify and treat nerve damage in COVID-19 patients. The study will be published December 1 in the journal Radiology.

Two New Causes of Nerve Damage

Previous research from Northwestern and Shirley Ryan AbilityLab found COVID-19 patients can experience nerve damage after being flipped onto their stomachs (prone positioning) in the ICU as a life-saving measure to help them breathe. This new paper demonstrates how advanced imaging aids this cohort of patients as well as two additional patient cohorts with COVID-19-related nerve damage:

  • Secondary to an inflammatory immune response that attacked the nerves or
  • From a hematoma (when blood collects outside of the blood vessels).

"Similar to how the body's immune response attacks the lungs in severe COVID cases, some patients have an immune response that affects their nerves," Deshmukh said. "Another group of patients developed hematomas as a complication from the blood thinners they were treated with when they had COVID."

Deshmukh said she hopes the findings will raise awareness of this imaging technology.

"I have to wonder if there are physicians out there who are seeing these otherwise young, healthy patients, and they don't know exactly what's wrong and they're thinking, 'What am I supposed to do for patients with post-COVID pain and weakness?'" Deshmukh said. "I want physicians and patients to be aware of the diagnostic options available due to recent innovations in technology, and inquire if advanced imaging might be right for them."

How the Technology Works

The imaging described in the paper includes ultra-high-resolution ultrasound and MR neurography (MRI of peripheral nerves, which impact the arms and legs). They can help localize where a patient's problem is, show the severity of nerve damage, how many nerves are affected and if the nerve damage also has impacted the muscles.

The advanced ultrasound technology is new, portable, less expensive and can sometimes be even better at detecting nerve damage than MRI, Deshmukh said. Ultrasound also can be performed on patients who are unable to tolerate MR imaging.

Guiding Treatment Decisions

If imaging technology discovers nerve damage caused by stretch injury because of prone positioning, Deshmukh said, that patient may be referred to a physician who specializes in rehabilitation or peripheral nerve surgery. If imaging finds nerve damage due to an inflammatory response, the patient may be better served by seeing a neurologist. If imaging reveals nerve damage from a hematoma, blood thinner medications would have to be adjusted immediately and the patient may even have to see a surgeon.

For COVID-19 patients and survivors with neuromuscular complications or "long-hauler" symptoms, imaging can help reveal the problem and guide further treatment.

All patients in the study had tested positive for COVID-19.

VIDEO: What Are The Long-term Cardiac Impacts of COVID-19 Infection in Long-hauler COVID Patients

For more information: www.northwestern.edu


Related Content

News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
News | Cardiac Imaging

February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image ...

Time February 28, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 28, 2024 — Royal Philips, a global leader in health technology, today announced a significant milestone as it ...

Time February 28, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — Median Technologies announced that the Company will be participating and speaking at the premier ...

Time February 27, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — As artificial intelligence (AI) is increasingly used in radiology, researchers caution that it’s ...

Time February 27, 2024
arrow
News | X-Ray

February 26, 2024 — AIxSCAN, Inc. began clinical trials in late 2023. The AIxSCAN, Inc. team is very pleased with the ...

Time February 26, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Time February 21, 2024
arrow
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Time February 20, 2024
arrow
Subscribe Now